Clinical trial
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
NCT00977938 is registered in ClinicalTrials.gov with Baim Institute for Clinical Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
- Lead sponsor
- Baim Institute for Clinical Research
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2009
- Completion date
- June 30, 2014
- Enrollment
- 25,682 (actual)
- Sites
- 256
Conditions
As the registry lists them; a condition with its own page is linked.